Cardinal Health Long-Term Investments 2010-2024 | CAH

Cardinal Health long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Cardinal Health long-term investments for the quarter ending September 30, 2024 were $M, a NAN% increase year-over-year.
  • Cardinal Health long-term investments for 2024 were $0B, a NAN% decline from 2023.
  • Cardinal Health long-term investments for 2023 were $0B, a NAN% decline from 2022.
  • Cardinal Health long-term investments for 2022 were $0B, a NAN% decline from 2021.
Cardinal Health Annual Long-Term Investments
(Millions of US $)
2024 $
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $692
2009 $
Cardinal Health Quarterly Long-Term Investments
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30 $394
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30 $692
2010-03-31 $805
2009-12-31 $897
2009-09-30 $902
2009-06-30
2009-03-31 $934
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $30.559B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.221B 20.52
Becton Dickinson (BDX) United States $68.842B 18.04
West Pharmaceutical Services (WST) United States $24.359B 49.75
Labcorp (LH) United States $19.953B 16.54
Cooper (COO) United States $18.615B 25.21
Align Technology (ALGN) United States $16.739B 32.03
Henry Schein (HSIC) United States $9.129B 17.39
Merit Medical Systems (MMSI) United States $5.997B 30.62
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
Patterson (PDCO) United States $2.729B 14.57
CONMED (CNMD) United States $2.091B 17.45
STAAR Surgical (STAA) United States $1.098B 40.53
Lifevantage (LFVN) United States $0.317B 42.18
Pro-Dex (PDEX) United States $0.145B 28.80